Page last updated: 2024-09-05

2-hexynyladenosine-5'-n-ethylcarboxamide and apnea

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with apnea in 1 studies

Compound Research Comparison

Studies
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Trials
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Recent Studies (post-2010)
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Studies
(apnea)
Trials
(apnea)
Recent Studies (post-2010) (apnea)
28027,6835051,643

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, G; Fredholm, BB; Kull, B; Lorenzen, A; Nilsson, C; Owman, C; Schwabe, U1

Other Studies

1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and apnea

ArticleYear
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Biochemical pharmacology, 1999, Jan-01, Volume: 57, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Kinetics; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Triazoles; Tritium

1999